Company / Book Value per Share
Vir Biotechnology, Inc. Book Value per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
$5.588
FY2025
5-year range
$3.327 / $15.843
FY2021-FY2025
Trend
-34.5%
vs FY2024
Sector context
#104 of 209
Health Care
What the data says
At $5.588, Vir Biotechnology, Inc.'s book value per share ranks #104 of 209 in the Health Care sector. Book Value per Share has declined for 3 consecutive years, from $15.843 in FY2022 to $5.588 in FY2025.
Based on SEC 10-K filings.
$5.588 in FY2025 with a 5-year CAGR of -3.4%.
Declined from $11.935 to $5.588 over the past 2 years.
Health Care sector context is included.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- -29.3%
- 5-Year CAGR
- -3.4%
- 10-Year CAGR
- -
Sector benchmark
#104 of 209 in Health CareTop 50% of 209This company $5.588 Sector average $189.406
▼
-97.0% below sector average
Key checks
Key Insights
- Vir Biotechnology, Inc.'s book value per share has declined for 3 consecutive years.
- 5-year CAGR of -3.4%, indicating a declining trend.
- In FY2025, book value per share decreased 34.5% year-over-year.
- Ranks #104 out of 209 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.77 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $5.588 | -34.5% |
| FY2024 | $8.535 | -28.5% |
| FY2023 | $11.935 | -24.7% |
| FY2022 | $15.843 | +376.2% |
| FY2021 | $3.327 | -50.0% |
| FY2020 | $6.659 | -86.1% |
| FY2019 | $47.855 | +304.8% |
| FY2018 | -$23.372 | +27.0% |
| FY2017 | -$32.02 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026